Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05603923 · ClinicalTrials.gov registry record · NA

Study of a PST-Trained Voice-Enabled Artificial Intelligence Counselor(SPEAC) for Adults With Emotional Distress (Phase 2)

A NA study, sponsored by University of Illinois at Chicago.

Completed
Registry status
NA
Development phase
200
Enrollment target

NCT05603923 is a NA study that has completed, run by University of Illinois at Chicago. The registered enrollment target is 200 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05603923, a NA study, has completed, sponsored by University of Illinois at Chicago.

COMPLETED
Registry status
NA
Development phase
200 participants
Enrollment target

Study Summary

Approximately 200 Participants with mild-to-moderate, untreated depression and/or anxiety will be randomly assigned (by chance, like flipping a coin) to 1 of 3 study groups: Lumen Coached Problem-Solving Treatment (PST) (n=100), Human Coached PST (n=50), and optional (delayed) Lumen Coached PST as waitlist control (n=50) to improve emotional health. All participants will complete assessments at baseline and at 18 weeks post randomization. Depending on the group assignment the PST program will be delivered by Lumen, a virtual voice-based coach on a study iPad, or by a human coach in person for the first session and then via videoconference or phone for the remaining 7 sessions. Participants assigned to the waitlist control group can receive the Lumen coached PST on a study iPad after completing their 18-week follow-up assessment. Participants will receive 8 coaching sessions to learn problem-solving skills and work on unresolved problems in daily living that may be interfering with their emotional well-being and contributing to depression and anxiety symptoms.

Interventions

  • BEHAVIORAL Lumen Coached PST Intervention.
  • BEHAVIORAL Human Coached PST Intervention.
  • BEHAVIORAL Optional (delayed) Lumen Coached PST (Waitlist control).

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2023-01-23
Est. Completion 2025-04-15
Phase NA

Sponsor

University of Illinois at Chicago

430 total trials

What the Registry Record Tells You About NCT05603923

The ClinicalTrials.gov registry entry for NCT05603923 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Lumen Coached PST Intervention. is the first listed.

NCT05603923 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05603923 about?

NCT05603923 is a clinical study titled "Study of a PST-Trained Voice-Enabled Artificial Intelligence Counselor(SPEAC) for Adults With Emotional Distress (Phase 2)". Approximately 200 Participants with mild-to-moderate, untreated depression and/or anxiety will be randomly assigned (by chance, like flipping a coin) to 1 of 3 study groups: Lumen Coached Problem-Solving Treatment (PST) (n=100), Human Coached PST (n=50), and optional (delayed) Lumen Coached PST as w...

What is the current status of trial NCT05603923?

This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2023-01-23. Estimated completion is 2025-04-15.

What interventions are being tested in trial NCT05603923?

The interventions under investigation include: Lumen Coached PST Intervention. (BEHAVIORAL), Human Coached PST Intervention. (BEHAVIORAL), Optional (delayed) Lumen Coached PST (Waitlist control). (BEHAVIORAL).

Who is sponsoring clinical trial NCT05603923?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.